Holen Sie sich die Stockscreener-App
1.92
0.00%
0.00
Schlusskurs vom Vortag:
$1.92
Offen:
$1.96
24-Stunden-Volumen:
361.33K
Relative Volume:
0.59
Marktkapitalisierung:
$71.77M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-14.67%
1M Leistung:
+0.52%
6M Leistung:
-22.58%
1J Leistung:
-44.67%
1-Tages-Spanne:
$1.82
$1.965
1-Wochen-Bereich:
$1.82
$2.32
52-Wochen-Spanne:
$1.23
$4.92
Metagenomi Inc Stock (MGX) Company Profile
Firmenname
Metagenomi Inc
Sektor
Branche
Telefon
(510) 871-4880
Adresse
5959 HORTON STREET, EMERYVILLE
Vergleichen Sie MGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
1.92 | 78.50M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-03-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-03-05 | Eingeleitet | TD Cowen | Outperform |
| 2024-03-05 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Metagenomi Inc Aktie (MGX) Neueste Nachrichten
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 25, 2024 in Metagenomi LawsuitMGX - ACCESS Newswire
Metagenomi, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before November 25, 2024 to Discuss Your RightsMGX - ACCESS Newswire
Metagenomi Sells The Gene-Editing Dream—But Risk Looms Large - Finimize
How does Metagenomi Inc. compare to its industry peersTremendous return rates - Jammu Links News
When is Metagenomi Inc. stock expected to show significant growthBreakneck growth rates - Jammu Links News
Published on: 2025-08-04 03:23:40 - Jammu Links News
Should I hold or sell Metagenomi Inc. stock in 2025Outstanding stock performance - Jammu Links News
Metagenomi Inc. Stock Analysis and ForecastGet real-time alerts on top-performing stocks - Jammu Links News
Is it the right time to buy Metagenomi Inc. stockOutstanding capital returns - Jammu Links News
How many analysts rate Metagenomi Inc. as a “Buy”High-performance investment picks - Jammu Links News
What catalysts could drive Metagenomi Inc. stock higher in 2025Double-digit growth - Jammu Links News
What analysts say about Metagenomi Inc. stockHigh-return market picks - jammulinksnews.com
How volatile is Metagenomi Inc. stock compared to the marketMarket-crushing stock picks - Jammu Links News
What is Metagenomi Inc. company’s growth strategyAchieve rapid capital gains with smart investing - Jammu Links News
Is Metagenomi Inc. stock overvalued or undervaluedRapidly growing investment returns - Jammu Links News
How strong is Metagenomi Inc. company’s balance sheetPowerful market insights - Jammu Links News
How does Metagenomi Inc. generate profit in a changing economyGet professional advice for portfolio optimization - Jammu Links News
Is Metagenomi Inc. a growth stock or a value stockExceptional trading results - Jammu Links News
Discover People are buying the wrong stock thinking it's part of OpenAI's Stargate Project - Quartz
What are analysts’ price targets for Metagenomi Inc. in the next 12 monthsInvest in high-yield stocks with confidence - Jammu Links News
Analyzing Metagenomi Inc. with risk reward ratio chartsFree Investment Playbook for Growing Markets - Newser
What is the risk reward ratio of investing in Metagenomi Inc. stockSmart Portfolio Data Feed For 2025 - Jammu Links News
Metagenomi Inc. stock trendline breakdownMomentum Entry Alerts with Risk Control - Newser
What makes Metagenomi Inc. stock price move sharplyCommunity Entry Consensus Trade Ideas Shared - metal.it
How Metagenomi Inc. stock performs during market volatilitySector-Wise Stock Strength Trend Analysis - Newser
Will Metagenomi Inc. stock benefit from AI tech trendsRisk Adjusted Technical Entry Plan Gains Followers - metal.it
Price momentum metrics for Metagenomi Inc. explainedProfit Target Stock Opportunity Monitor Activated - metal.it
Metagenomi (MGX) Presents Latest in Gene Editing Technologies - Insider Monkey
Metagenomi Advances Gene Editing Technologies with Presentations at ASGCT Meeting - AInvest
Is Metagenomi Inc. Stock a Good Fit for Conservative InvestorsWeekly Market Direction and Sector Summary - Newser
Metagenomi Inc. Stock Support and Resistance Levels You Should KnowFree Real Market Momentum Signal Generator - Newser
Is Metagenomi Inc. building a consolidation baseAsset Growth Pattern and Return Summary - Newser
Will Metagenomi Inc. stock benefit from AI tech trends Fundamental + Technical Combined Watchlist - Newser
Why is Metagenomi Inc. stock attracting strong analyst attentionUnlock powerful trading signals for profits - Jammu Links News
Finanzdaten der Metagenomi Inc-Aktie (MGX)
Es liegen keine Finanzdaten für Metagenomi Inc (MGX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):